Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib + 5-FU/Leucovorin in Advanced Biliary Tract Cancer
NCT01153750Phase 2Completed
- Sponsor
- Uniklinikum Dresden
- Start
- Apr 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in cholangiocarcinoma (CCA), gallbladder carcinoma, sponsored by Uniklinikum Dresden. Started Apr 2007; status: completed.
02
Drugs
03
Conditions
cholangiocarcinoma (CCA)gallbladder carcinoma
Beyond the preview
Go deeper on NCT01153750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01153750.